It acts as a dual agonist for two important hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Alitretinoin, a vitamin A derivative, has shown efficacy in treating hyperkeratotic CHE, with studies reporting significant improvements in Physician Global Assessment (PGA) scores [92]
Vitamin B12 is generally well tolerated and safe for most people, however, as with any supplement regime, if you have concerns or questions regarding the dose you should take, check with your GP first
Furthermore, oral peptides offer increased compliance in research settings
Semaglutide is generally associated with GLP-1 receptor research
But I think theres also probably going to be 5 or 10 new medications that come to market in the next few years, just given if you look at the clinical studies and the FDA pipeline